Preoperative Screening for Hepatitis B, C, and HIV in Surgical Patients
Routine universal serologic screening for hepatitis B, C, and HIV is not recommended for all surgical patients; instead, use risk-based screening combined with universal precautions for all procedures.
Risk-Based Screening Approach
When to Screen for Hepatitis B
Screen high-risk patients undergoing major abdominal, orthopedic, or gynecological surgery, and consider screening all patients undergoing open heart surgery where blood exposure risk is substantial. 1
Take a detailed history focusing on:
Physical examination should identify needle puncture sites or other signs of high-risk behavior 1
When to Screen for HIV
HIV antibody testing should only be performed on clinical grounds for high-risk patients, and only after counseling and obtaining informed consent. 1
HIV testing is required for:
Consider testing for patients with risk factors:
- Homosexual or bisexual males 1
- Intravenous drug abusers 1
- Persons with penetrative sexual contact with partners from high HIV prevalence areas 1
- Recipients of unscreened blood transfusions in high-prevalence areas 1
- Hemophilic patients who received untreated blood products 1
- Sexual partners of any of the above 1
- Children born to seropositive mothers 1
When to Screen for Hepatitis C
Hepatitis C screening should follow similar risk-based criteria as HIV, as most patients at high risk for HIV are also at high risk for hepatitis C. 1
- The detection rate for hepatitis C (5.2%) is significantly higher than HIV (1.6%) or hepatitis B surface antigen (1.4%) in surgical populations 2
Geographic and Surgical Risk Considerations
High-Prevalence Areas
In areas of high HIV or hepatitis prevalence, all patients admitted for emergency surgery should be considered high risk, and preoperative screening should be considered essential. 1
- Emergency operations requiring full precautions include:
Low-Prevalence Areas
In areas of low HIV prevalence (most of the United Kingdom and similar regions), additional precautions and routine screening may not be necessary. 1
- A study from San Francisco showed that knowing HIV status made no difference in the incidence of sharps injuries when universal precautions were implemented 1
Evidence Against Universal Screening
The cost-benefit ratio of routine universal screening is poor, with very low detection rates of new infections. 3
In a 10-year study of 10,011 screened orthopedic surgery patients, only 4 cases (0.4‰) of previously unknown infection were detected 3
Routine testing identifies abnormalities in only 0.8-22% of cases, with management changes occurring in merely 1.1-4% of abnormal results 4
Alternative to Serologic Screening: Clinical History
The primary screening method should be a careful history including specific questions about:
- Sexual behavior and number of partners 1
- Drug abuse history 1
- Travel to HIV or hepatitis endemic areas 1
- Previous blood transfusions 1
- Occupational exposures 1
Universal Precautions: The Foundation
Regardless of screening results, universal precautions must be implemented for all surgical procedures. 1
Standard Precautions for All Patients
- All surgeons must be vaccinated against hepatitis B 1
- Cover all cuts and abrasions with waterproof dressings 1
- Never pass sharps hand to hand 1
- Never guide needles with fingers 1
- Never resheath needles 1
- Dispose of all sharps safely into approved containers 1
- Regular hand-washing and basic hygiene 1
Additional Precautions for Known or High-Risk Cases
- Double gloving for high-risk patients (though this decreases sensitivity) 1
- Plastic aprons and disposable gloves when handling used materials 1
- Disinfect theatre floor with hypochlorite (1000 ppm available chlorine) between cases 1
Important Caveats
Testing for HIV alone would detect only 24% of patients infected with a bloodborne pathogen, as hepatitis C is more prevalent and predictive of co-infection. 2
Screening is expensive and the evidence shows that universal precautions are more effective than selective precautions based on known serostatus. 1
If screening is performed, informed consent after counseling is mandatory for HIV testing. 1
The primary benefit of screening may be for patient management (early treatment initiation) rather than infection control, as universal precautions should be used regardless. 1